Skip to content
General News, Medical Health Aged Care

Adelaide lightens the overload of Australia’s most common genetic disorder

Haemochromatosis Australia 2 mins read

MEDIA RELEASE 

Adelaide Oval, Parliament House and around 100 well-known buildings and landmarks across Australia will turn red every from tonight until the 7 June, shining a light on an extremely common genetic condition that most people have never heard of.

It is part of a worldwide initiative to raise awareness of haemochromatosis – also known as iron overload – and to prompt people to get tested. Most people know that having too little iron in your body can cause anaemia, which is characterised by tiredness and lethargy, but few people know that the same symptoms can also be caused by having too much iron.

The hereditary condition, which is passed on from both biological parents, is simple to detect and treat but if undiagnosed or ignored can lead to serious and life-threatening illness, including liver disease and diabetes. One in seven Australians carry one copy of the defective gene, while and one in 200 Australians have two copies, which puts them at high risk of developing the condition.

Dr Dan Johnstone, an iron researcher who also has the condition, says early detection is key to minimising or preventing permanent damage. “Awareness of haemochromatosis is more important now than ever as early diagnosis will help save lives, cut health costs and reduce unnecessary suffering for so many individuals and families. Everybody is different; some people will have early symptoms of fatigue or joint aches while others won’t know they have the condition until the damage is already done. Anyone who suspects they may have this condition should ask their GP for a blood test. Haemochromatosis is not a burden in your life if you get on to it early. Early diagnosis is key to managing and reducing complications. It is usually managed by a regime of therapeutic blood donations, at an Australian Red Cross Lifeblood donor centre. This is a classic win-win situation, benefiting both the individual and the community,” said Dr Johnstone.

Haemochromatosis Australia spokesperson, Tony Moorhead, said, “Despite being the most common genetic disorder in Australia, haemochromatosis is often underdiagnosed because people don’t know about it and symptoms are non-specific. Unfortunately, most of those affected aren’t diagnosed until aged in their mid-forties and already suffering ill health. “There are people with the condition who should have been diagnosed decades earlier. This would have reduced the suffering, medical cost and even loss of life that results from iron overload. If haemochromatosis is detected early enough it is completely preventable – those affected need never get sick, they simply need to donate blood to maintain normal iron levels and their health.” Mr Moorhead says. “Hereditary haemochromatosis is estimated to cost Australia’s health system about $280 million annually and to add further cost burdens by compounding other chronic conditions.” Haemochromatosis is easy to test, simple to treat but tragic to ignore. -

 

ENDS Landmarks lighting up can be found here: www.ha.org.au/whats-on/world-haemochromatosis-week/lighten-the-overload/ 


Key Facts:

* Australia's most common genetic disorder, that most have never heard of

* World Haemochromatosis Awareness Week June 1 - 7 

* Interviews Available

* Landmarks lighting up red can be found here: www.ha.org.au/whats-on/world-haemochromatosis-week/lighten-the-overload/ 


About us:

To find out more visit www.ha.org.au/haemochromatosis


Contact details:

Media enquiries:

Kellie Curtain M: 0412339690 [email protected] 

More from this category

  • Medical Health Aged Care
  • 10/03/2026
  • 16:28
Phebra

Phebra launches Rapiblyk® in Australian healthcare settings

Australian Pharmaceutical company Phebra (‘Company’) has announced the launch of Rapiblyk® (landiolol hydrochloride), an ultra‑short‑acting, cardio-selective receptor antagonist, indicated for rapid control of ventricular rate in patients with severe, acute cardiac arrhythmias (irregular rapid heart rate) in critical care settings. Clinical studies have demonstrated that Rapiblyk® enables safe, effective heart rate control with limited impact on blood pressure and inotropy (heart contractility). Rapiblyk® has a very short half life delivering a fast onset and offset of action. This provides clinicians with a higher level of precision in life-threatening situations. Phebra CEO Andre Vlok highlighted how Rapiblyk® strengthens the company's critical…

  • Foreign Affairs Trade, General News
  • 10/03/2026
  • 16:12
Parliament of Australia

Austrade’s role in supporting trade and investment relations with Africa

TheJoint Standing Committee on Foreign Affairs, Defence and Tradethrough its Trade Subcommittee will hold a public hearing with Austrade for itsinquiry into strengthening Australia’s trade and investment relations with Africa. Chair of the Trade Subcommittee, Mrs Fiona Phillips MP, said ‘Austrade plays a valuable role in the trade and investment environment by supporting Australian businesses to expand and diversify in international markets. Australian businesses rely on Austrade’s expertise to provide advice on opportunities, market entry, and local business practices to engage with African markets. Austrade is therefore positioned to provide the Subcommittee with valuable insights into its terms of reference.’…

  • Medical Health Aged Care
  • 10/03/2026
  • 16:09
Dementia Australia

On this weekend – Memory Walk & Jog Adelaide!

The 2026 Adelaide Memory Walk & Jog is fast approaching, with the much-anticipated event taking place this weekend on Sunday 15 March at Wigley Reserve, Glenelg. With the big day kicking off at 7:30am, we welcome everyone in the Adelaide community to join their fellow participants as they walk, jog or run for better brain health and to help raise money in support of people living with dementia, their families and carers.Join MC Mark Gibson for a wonderful fun, family friendly day out. More than 960 people have already signed-up to take part – but there’s always room for more…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.